Biomarin Pharmaceutical (BMRN) Tax Rate Growth (1y) (2010 - 2026)
Biomarin Pharmaceutical (BMRN) Tax Rate Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,200.25 Bn | 66,199.96 Bn | - |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 471.75 Bn | 466.96 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.69 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.87 Bn | 61.12 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.43 Bn | 62.43 Bn | - |
| 8 | Argenx Se | 55.86 Bn | 50.68 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn |
| 10 | Biomarin Pharmaceutical | 11.72 Bn | 9.50 Bn | 571.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 326.00 |
| Dec 31, 2025 | -9,787.00 |
| Sep 30, 2025 | -3,789.00 |
| Jun 30, 2025 | 36.00 |
| Mar 31, 2025 | 601.00 |
| Dec 31, 2024 | 3,177.00 |
| Sep 30, 2024 | 1,800.00 |
| Jun 30, 2024 | -197.00 |
| Mar 31, 2024 | 559.00 |
| Dec 31, 2023 | -10,400.00 |
| Sep 30, 2023 | 25,247.00 |
| Jun 30, 2023 | 24.00 |
| Mar 31, 2023 | 43.00 |
| Dec 31, 2022 | 8,555.00 |
| Sep 30, 2022 | -27,031.00 |
| Jun 30, 2022 | 1,204.00 |
| Mar 31, 2022 | -1,524.00 |
| Dec 31, 2021 | -12,331.00 |
| Sep 30, 2021 | -136,108.00 |
| Jun 30, 2021 | -2,238.00 |